An ethics framework for big data in health and research V Xafis, GO Schaefer, MK Labude, I Brassington, A Ballantyne, HY Lim, ... Asian Bioethics Review 11 (3), 227-254, 2019 | 113 | 2019 |
The perfect moral storm: diverse ethical considerations in the COVID-19 pandemic V Xafis, GO Schaefer, MK Labude, Y Zhu, LY Hsu Asian Bioethics Review 12, 65-83, 2020 | 80 | 2020 |
Openness in big data and data repositories: The application of an ethics framework for big data in health and research V Xafis, MK Labude Asian Bioethics Review 11 (3), 255-273, 2019 | 29 | 2019 |
Genetic affinity and the right to ‘three-parent IVF’ GO Schaefer, MK Labude Journal of assisted reproduction and genetics 34, 1577-1580, 2017 | 20 | 2017 |
Perspectives of Singaporean biomedical researchers and research support staff on actual and ideal IRB review functions and characteristics: a quantitative analysis MK Labude, L Shen, Y Zhu, GO Schaefer, C Ong, V Xafis PloS One 15 (12), e0241783, 2020 | 9 | 2020 |
Germline genome modification through novel political, ethical, and social lenses V Xafis, GO Schaefer, MK Labude, Y Zhu, S Holm, RSY Foo, PS Lai, ... PLoS Genetics 17 (9), e1009741, 2021 | 8 | 2021 |
International reporting mechanism for unethical germline gene editing experiments is needed GO Schaefer, MK Labude, Y Zhu, RSY Foo, V Xafis Trends in Biotechnology 39 (5), 427-430, 2021 | 8 | 2021 |
Germline genome editing: Moratorium, hard law, or an informed adaptive consensus? T Kaan, V Xafis, GO Schaefer, Y Zhu, MK Labude, R Chadwick PLoS Genetics 17 (9), e1009742, 2021 | 7 | 2021 |
Making sense of it all: Ethical reflections on the conditions surrounding the first genome-edited babies Q Chen, Y Ma, M Labude, GO Schaefer, V Xafis, P Mills Wellcome Open Research 5, 2020 | 7 | 2020 |
Two kinds of embryo research: four case examples J Savulescu, M Labude, C Barcellona, Z Huang, MK Leverentz, V Xafis, ... Journal of Medical Ethics 48 (9), 590-596, 2022 | 6 | 2022 |
The Idea of Justice from a Rawlsian Perspective M Labude, T Pogge Journal of Human Development and Capabilities 11 (4), 609-613, 2010 | 5 | 2010 |
A new framework for self-regulation:'Human Biomedical Research Act 2015' MK Labude Singapore Journal of Legal Studies, 194-208, 2016 | 3 | 2016 |
Vulnerability and the Ethics of Human Germline Genome Editing MK Labude, V Xafis, PS Lai, C Mills The CRISPR journal 5 (3), 358-363, 2022 | 2 | 2022 |
Ethical considerations of preconception and prenatal gene modification in the embryo and fetus CNZ Mattar, MK Labude, TN Lee, PS Lai Human Reproduction 36 (12), 3018-3027, 2021 | 2 | 2021 |
Competencies of Member States concerned and of Ethics Committees to assess trial applications under the new EU Clinical Trials Regulation MK Labude, LEE Tsung-Ling European Journal of Risk Regulation 8 (1), 178-185, 2017 | 2 | 2017 |
Correction: Perspectives of Singaporean biomedical researchers and research support staff on actual and ideal IRB review functions and characteristics: A quantitative analysis MK Labude, L Shen, Y Zhu, GO Schaefer, C Ong, V Xafis Plos one 16 (3), e0248613, 2021 | 1 | 2021 |
Correction to: the perfect moral storm: diverse ethical considerations in the COVID-19 pandemic V Xafis, GO Schaefer, MK Labude, Y Zhu, LY Hsu Asian Bioethics Review 12 (2), 85, 2020 | 1 | 2020 |
Ethically Justified Restrictions on Citizen Science: A Perspective from Singapore M Labude, V Xafis The American Journal of Bioethics 19 (8), 38-40, 2019 | 1 | 2019 |
Big Data: Ethical Considerations GO Schaefer, MK Labude, HU Nasir The Palgrave Handbook of Philosophy and Public Policy, 593-607, 2018 | 1 | 2018 |
Genome Editing for Human Benefit: Ethics, Engagement and Governance M Labude, O Schaefer, V Xafis, CW Leong, A Erler, T Lysaght, LP San | | |